Does genetic screening improve diagnosis and outcomes in individuals with NPPA-associated atrial dilated cardiomyopathy?
Genetic screening in patients with isolated atrial dysfunction may facilitate earlier diagnosis and personalized management of NPPA-associated atrial dilated cardiomyopathy.
Broader implementation of genetic screening in selected individuals with isolated atrial dysfunction may support earlier diagnosis, personalized treatment, and better outcomes in this ultrarare condition.
Forleo et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: